Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD).
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …

Pulmonary hypertension (PH) is present in an important proportion of patients with interstitial
lung diseases (ILDs), encompassing a large, heterogeneous group of diffuse parenchymal …

Pulmonary hypertension is a debilitating condition that frequently develops in the setting of
interstitial lung disease, likely related to chronic alveolar hypoxemia and pulmonary vascular …

Interstitial lung diseases (ILDs) comprise a broad and heterogeneous group of more than
two hundred diseases with common functional characteristics. Their diagnosis and …

Pulmonary hypertension (PH) is a common complication of interstitial lung diseases (ILDs),
particularly in idiopathic pulmonary fibrosis and ILD associated with connective tissue …

Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common
and underrecognised. The presence of PH in the setting of lung disease has been …

Pulmonary hypertension associated with interstitial lung disease is now frequently
recognized and is associated with substantial morbidity and mortality. Various new …

Pulmonary hypertension, frequently complicating the course of patients with fibrotic
interstitial lung disease, is associated with significantly increased morbidity and mortality …

Pulmonary hypertension (PH) is known to complicate various forms of interstitial lung
disease (ILD), including idiopathic pulmonary fibrosis, the interstitial pneumonias and …

Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases.
The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly …